Frazier Life Sciences Management, L.P. Aura Biosciences, Inc. Put Options Transaction History
Frazier Life Sciences Management, L.P.
- $1.9 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AURA
# of Institutions
103Shares Held
51.4MCall Options Held
0Put Options Held
0-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$48 Million22.54% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$33.9 Million0.05% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR4.62MShares$32.1 Million1.33% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.37MShares$30.3 Million0.94% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$21.1 Million5.39% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $203M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...